Parexel partnering with Eli Lilly to support building a clinical trial learning and development program in China.

The acquisition is expected to bolster Biotage’s presence as a separations company within the growing biomolecule arena.

Germany's Merck is poised to expand its R&D facilities in China next year.

Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.

U.K.-based CRO Fusion Antibodies is partnering with Analytics Engines.

U.K.-based startup Fluidic Analytics reels in $31 million in a round of fundraising.

UCB partners with Verint Systems to launch a new app for Parkinson’s patients.

Adial Pharmaceutical taps Crown CRO to manage phase 3 trials for the company’s treatment for alcohol use disorder.